Fortune Brands recently announced it will consolidate its U.S offices into one headquarters, taking over two of three office buildings previously owned by Horizon Therapeutics, then Amgen Inc., at ...

Khaite is in the midst of a retail expansion, with its first West Coast store opening at South Coast Plaza at the end of January, and a new lease signed for Los Angeles. Lauren Sanchez's Inaugural ...

Analyst Swayampakula Ramakanth of H.C. Wainwright maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report), boosting the price ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious ...

While most of its current revenue comes from the contract manufacturing business, Samsung Biologics aims to increase its exposure in the contract development organization business, which provides a ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

IBM, which already had at least 270,000 square feet at the 26-story Midtown South office building, signed a 15-year lease and ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

SAN DIEGO, CA - Dermata Therapeutics , Inc. (NASDAQ:DRMA) and Revance Therapeutics, Inc. (Nasdaq: NASDAQ:RVNC), two ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio through the acquisition and expansion of ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...